ZTA Biotech, a Budapest-based biotech startup has announced the breakthrough development of a COVID-19 antibody (IgG) test using the ELISA protocol. This new detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease. Early results have proven 100% in specificity after testing 280 samples, and 100% sensitivity by testing 260 samples of recovered and symptomatic patients....
BioChromato Inc. has published an interview with the Department of Medicinal Chemistry and Molecular Pharmacology at Purdue University (Indiana, USA) that explains how the Smart Evaporator C1 has assisted them in isolating and purifying novel compounds from DMSO solutions for potential pharmaceutical use. Because the US Federal Drug Administration (FDA) does not approve DMSO formulations for human administration, researchers at Purdue University wanted to synthesise a new Platinum (IV) chloride complex...
Autoscribe Informatics took the opportunity in a recent webinar to discuss the much-misunderstood subject of LIMS validation. Within regulated environments LIMS validation is a vital process, and yet is a subject that is open to many different interpretations. Regulatory bodies throughout the world, such as the US Food and Drug Administration (FDA), require that software systems be tested and proven to work as intended....
Illumina, Inc. is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). This new and integrated bioinformatics solution provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment.
ZEISS introduces ZEISS Solutions Lab, an innovative service, that provides its customers with rapid access to new applications for their microscopy systems or correlative microscopy suites. ZEISS Solutions Lab enables customers to select, or to drive demand for module-based workflows built on ZEISS software packages for a wide variety of requirements specific to their research needs...
New research on the structure and dynamics of a branched form of DNA called a three-way junction could lead to more effectively targeted treatments for degenerative disorders like Huntington’s Disease, scientists say. In a new paper published in the journal Nature Communications, chemists from the University of Glasgow show for the first time how three-way DNA junctions undergo unexpected rearrangements in their structure....
Excalibur Healthcare Services Ltd, a leading UK-based provider of high-quality medical products and services, has announced that its Rapid SARS COV-2 Antigen Screening test is the first ever lateral flow antigen test to receive regulatory approval for use in mass screening for COVID-19 in asymptomatic, pre-symptomatic and symptomatic populations....
The International Institute for Sustainable Laboratories (I2SL) and MyGreenLab have partnered again to reward the best concept to improve cold storage regarding sustainability: The Freezer Challenge 2021. The users can earn points by taking actions from good management practices, temperature tuning, and other areas, as well as for sharing information about best practices. Awards will be given to those who have done the most to save energy and improve their sample storage...
ZEISS announces that it has formed a research collaboration partnership with the Max Planck Florida Institute for Neuroscience (MPFI). Using an LSM 980 NLO next generation confocal microscope supplied by ZEISS, MPFI will investigate using implanted GRadient INdex (GRIN) lenses in combination with the Airyscan 2 area detector for deep brain functional neuroscience research....
Mogrify Limited, a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, and the MRC Laboratory of Molecular Biology (LMB), a world-class research laboratory dedicated to understanding important biological processes at the molecular level, today announced an exploratory research collaboration. The project aims to develop novel protein expression systems by leveraging recent advances in direct cell reprogramming...
JEOL USA awarded two Grand Prizes to winners of its 2020 Electron Microscopy Image Contest, and kicked off its 2021 Image Contest at the beginning of the new year. The annual contest showcases JEOL microscope users’ artistically or esthetically pleasing images with good composition, sharp focus, and technical competency, especially in the use of accelerating voltage...
Scientists sequencing virus samples from the first confirmed cases of COVID-19 in Scotland (and through the first wave) have found evidence of community transmission, driven by multiple introductions through international travel, as early as February 2020. In new research, led by the University of Glasgow and published in Nature Microbiology, researchers have been able to confirm that SARS-CoV-2, the virus which causes COVID-19, had multiple introductions to Scotland in early 2020, mainly from European countries such as Italy and Spain....
Through this Acquisition, PerkinElmer will grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection to better serve customers around the world. Moreover, the deal will enable PerkinElmer to combine its channel expertise and leading workflow and testing capabilities with Oxford Immunotec’s leading proficiencies in T cell immunology with its proprietary test kits for latent tuberculosis....
Asynt has supplied Polymer Mimetics (Liverpool, UK) with a range of synthetic chemistry equipment to exploit novel chemistries to produce a new generation of high-performance polymers. Polymer Mimetics is a joint venture between the University of Liverpool, and Scott Bader Company Ltd. building upon a new polymerisation process developed by Professor Steve Rannard from the University’s Department of Chemistry....
AMSBIO has published an interview with researchers at Yamaguchi University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Japan, that covers their groundbreaking work to develop cell regeneration therapies for liver cirrhosis. The interview covers the involvement of the Graduate School of Medicine in the development of StemFit® for Mesenchymal Stem Cell (MSC), a new chemically defined medium which minimizes the risk of hazardous animal derived ingredients....
LSBio™ a leading provider of antibodies and life science research reagents, is pleased to announce its acquisition of Redcar, UK-based Absolute Antibody, Ltd. and its sister company Kerafast. LSBio provides IHC-validated reagent antibodies and services to the global community of academic, pharmaceutical and biotech researchers. The Company has built a catalog of more than 750,000 reagent antibodies, assay kits, proteins, and biochemicals, and its acquisition of Absolute Antibody and Kerafast...
Excellims Corporation (Excellims), a leading provider of high performance ion mobility spectrometers (HPIMS) / mass spectrometry (MS), has won The Analytical Scientist Innovation Award (TASIA) 2020. TASIAs showcase the technologies driving progress in measurement science. The award recognizes that HPIMS brings the power of state-of-the-art Ion Mobility out of the lab: enabling high resolution and sensitive chemical detection at the point of need...
Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, has announced plans to offer a new synthetic RNA control that includes the new variant of SARS-CoV-2 circulating in the United Kingdom and South Africa. This new variant strain of SARS-CoV-2 contains multiple spike protein mutations as well as mutations in other areas of the viral genome....
Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase III PROVENT trial which will evaluate AstraZeneca’s long-acting antibody combination, AZD7442, for the potential prevention of COVID-19. The double-blind, placebo-controlled trial will include adult volunteers who have no history of COVID-19 and have an increased risk of infection...
Autoscribe Informatics, a leading global laboratory informatics provider, announced the release of a new white paper examining the role of a Laboratory Information Management System (LIMS) in supporting ISO17025 accreditation. The white paper explores the ways in which a Laboratory Information Management System (LIMS) can play a key role in achieving, maintaining, and benefiting from ISO17025 accreditation.
Lonza and the Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organization established to provide the UK’s first strategic vaccine development and advanced manufacturing capability, announced a project to implement the MODA-EM™ Solution to automate quality control (QC) in the new facility. VMIC plans to implement the MODA-EM™ Solution as part of its strategy to develop a state-of-the-art manufacturing center due to open in 2021 – fast-tracked to open a year ahead of schedule...
Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Systems (LIMS), kicks off the 2021 LIMS Webcast Series on Wednesday, January 20th with LIMS – On-Premises or SaaS (Cloud) Deployment: Which is Right for My Laboratory? When selecting a LIMS today, organizations have deployment options. Traditionally, laboratories deployed the LIMS software on-site...
ZTA Biotech, a Budapest-based biotech startup has announced the breakthrough development of a COVID-19 antibody (IgG) test using the ELISA protocol. This new detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease. Early results have proven 100% in specificity after testing 280 samples, and 100% sensitivity by testing 260 samples of recovered and symptomatic patients....
BioChromato Inc. has published an interview with the Department of Medicinal Chemistry and Molecular Pharmacology at Purdue University (Indiana, USA) that explains how the Smart Evaporator C1 has assisted them in isolating and purifying novel compounds from DMSO solutions for potential pharmaceutical use. Because the US Federal Drug Administration (FDA) does not approve DMSO formulations for human administration, researchers at Purdue University wanted to synthesise a new Platinum (IV) chloride complex...
Autoscribe Informatics took the opportunity in a recent webinar to discuss the much-misunderstood subject of LIMS validation. Within regulated environments LIMS validation is a vital process, and yet is a subject that is open to many different interpretations. Regulatory bodies throughout the world, such as the US Food and Drug Administration (FDA), require that software systems be tested and proven to work as intended....
Illumina, Inc. is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). This new and integrated bioinformatics solution provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment.
ZEISS introduces ZEISS Solutions Lab, an innovative service, that provides its customers with rapid access to new applications for their microscopy systems or correlative microscopy suites. ZEISS Solutions Lab enables customers to select, or to drive demand for module-based workflows built on ZEISS software packages for a wide variety of requirements specific to their research needs...
New research on the structure and dynamics of a branched form of DNA called a three-way junction could lead to more effectively targeted treatments for degenerative disorders like Huntington’s Disease, scientists say. In a new paper published in the journal Nature Communications, chemists from the University of Glasgow show for the first time how three-way DNA junctions undergo unexpected rearrangements in their structure....
Excalibur Healthcare Services Ltd, a leading UK-based provider of high-quality medical products and services, has announced that its Rapid SARS COV-2 Antigen Screening test is the first ever lateral flow antigen test to receive regulatory approval for use in mass screening for COVID-19 in asymptomatic, pre-symptomatic and symptomatic populations....
The International Institute for Sustainable Laboratories (I2SL) and MyGreenLab have partnered again to reward the best concept to improve cold storage regarding sustainability: The Freezer Challenge 2021. The users can earn points by taking actions from good management practices, temperature tuning, and other areas, as well as for sharing information about best practices. Awards will be given to those who have done the most to save energy and improve their sample storage.
ZEISS announces that it has formed a research collaboration partnership with the Max Planck Florida Institute for Neuroscience (MPFI). Using an LSM 980 NLO next generation confocal microscope supplied by ZEISS, MPFI will investigate using implanted GRadient INdex (GRIN) lenses in combination with the Airyscan 2 area detector for deep brain functional neuroscience research....
Mogrify Limited, a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, and the MRC Laboratory of Molecular Biology (LMB), a world-class research laboratory dedicated to understanding important biological processes at the molecular level, today announced an exploratory research collaboration. The project aims to develop novel protein expression systems by leveraging recent advances in direct cell reprogramming...
JEOL USA awarded two Grand Prizes to winners of its 2020 Electron Microscopy Image Contest, and kicked off its 2021 Image Contest at the beginning of the new year. The annual contest showcases JEOL microscope users’ artistically or esthetically pleasing images with good composition, sharp focus, and technical competency, especially in the use of accelerating voltage...
Through this Acquisition, PerkinElmer will grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection to better serve customers around the world. Moreover, the deal will enable PerkinElmer to combine its channel expertise and leading workflow and testing capabilities with Oxford Immunotec’s leading proficiencies in T cell immunology with its proprietary test kits for latent tuberculosis....
Asynt has supplied Polymer Mimetics (Liverpool, UK) with a range of synthetic chemistry equipment to exploit novel chemistries to produce a new generation of high-performance polymers. Polymer Mimetics is a joint venture between the University of Liverpool, and Scott Bader Company Ltd. building upon a new polymerisation process developed by Professor Steve Rannard from the University’s Department of Chemistry....
AMSBIO has published an interview with researchers at Yamaguchi University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Japan, that covers their groundbreaking work to develop cell regeneration therapies for liver cirrhosis. The interview covers the involvement of the Graduate School of Medicine in the development of StemFit® for Mesenchymal Stem Cell (MSC), a new chemically defined medium which minimizes the risk of hazardous animal derived ingredients....
LSBio™ a leading provider of antibodies and life science research reagents, is pleased to announce its acquisition of Redcar, UK-based Absolute Antibody, Ltd. and its sister company Kerafast. LSBio provides IHC-validated reagent antibodies and services to the global community of academic, pharmaceutical and biotech researchers. The Company has built a catalog of more than 750,000 reagent antibodies, assay kits, proteins, and biochemicals, and its acquisition of Absolute Antibody and Kerafast...
Excellims Corporation (Excellims), a leading provider of high performance ion mobility spectrometers (HPIMS) / mass spectrometry (MS), has won The Analytical Scientist Innovation Award (TASIA) 2020. TASIAs showcase the technologies driving progress in measurement science. The award recognizes that HPIMS brings the power of state-of-the-art Ion Mobility out of the lab: enabling high resolution and sensitive chemical detection at the point of need...
Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, has announced plans to offer a new synthetic RNA control that includes the new variant of SARS-CoV-2 circulating in the United Kingdom and South Africa. This new variant strain of SARS-CoV-2 contains multiple spike protein mutations as well as mutations in other areas of the viral genome....
Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase III PROVENT trial which will evaluate AstraZeneca’s long-acting antibody combination, AZD7442, for the potential prevention of COVID-19. The double-blind, placebo-controlled trial will include adult volunteers who have no history of COVID-19 and have an increased risk of infection...
Autoscribe Informatics, a leading global laboratory informatics provider, announced the release of a new white paper examining the role of a Laboratory Information Management System (LIMS) in supporting ISO17025 accreditation. The white paper explores the ways in which a Laboratory Information Management System (LIMS) can play a key role in achieving, maintaining, and benefiting from ISO17025 accreditation.
Lonza and the Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organization established to provide the UK’s first strategic vaccine development and advanced manufacturing capability, announced a project to implement the MODA-EM™ Solution to automate quality control (QC) in the new facility. VMIC plans to implement the MODA-EM™ Solution as part of its strategy to develop a state-of-the-art manufacturing center due to open in 2021 – fast-tracked to open a year ahead of schedule...
Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Systems (LIMS), kicks off the 2021 LIMS Webcast Series on Wednesday, January 20th with LIMS – On-Premises or SaaS (Cloud) Deployment: Which is Right for My Laboratory? When selecting a LIMS today, organizations have deployment options. Traditionally, laboratories deployed the LIMS software on-site...